Skip to content
Visit Rutgers.edu
Visit BHI
Newsletter Sign-up
Contact Us
Search Rutgers
About Us
Note From the Director
Our Mission
Our Values
Our People
Frequently Asked Questions
Job Openings
Annual Report
About Addiction
Facts and Figures
Participate in Research
Addiction in the News
Media Relations: Experts Available to Comment
Research
Our Research
Basic Science
Epidemiology, Etiology & Prevention
Treatment & Recovery
Public Policy
Active Projects
Resources for Researchers
Research Community Partnership
IFPR – Rutgers Research Collaboration
BHI-RARC Mock Grant Review Program
Training
Training Programs
Meet Our Trainees
Student Research Opportunities
Postdoctoral Research Positions
Research Opportunity Forum Board
Science Communication
Clinical Services
Rutgers Services
Clinical Trials Seeking Participants
News & Events
2025 RARC Fall Symposium
RARC Videos
RARC Blog
Event Calendar
RARC Newsletter & Archives
Support the RARC
Visit Rutgers.edu
Newsletter Sign-up
Search Rutgers
Get Help
RARC Blog
Category:
Uncategorized
FDA Approves First Over-the-Counter Naloxone Nasal Spray
Excess Calories During Development Alter the Brain and Spur Adult Overeating
Can Cannabis Use Disorder Be Accurately Diagnosed?
Naloxone Prescriptions Increased at U.S. Hospitals Between 2012 and 2019
Buprenorphine After Nonfatal Opioid Overdose Results in Reduced Risk of Overdose Death
Inmates With Opioid Addiction Report Peer Navigators Are Crucial for Successful Community Reentry
Announcing the Spring 2023 RARC Pilot Grant Program Awardees!
RARC Researchers Propose Recommendations for Cannabis use Disorder Diagnosis
Invitation to the Rutgers Addiction Research Center Interest Group on Cannabis
2023 NJ ACTS Fellowship
The War on Fentanyl
RARC Researcher, Dr. David Barker, Receives New NJFS Grant
Previous Page
Next Page